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AbstrAct
Objective This study aimed to investigate both atopic and 
non-atopic comorbid symptoms and diseases in children 
with physician-diagnosed atopic disorders (atopic eczema, 
asthma and allergic rhinitis).
Methods All children aged 0–18 years listed in a 
nationwide primary care database (the Netherlands 
Institute for Health Services Research-Primary Care 
Database) with routinely collected healthcare data in 
2014 were selected. Children with atopic disorders 
were matched on age and gender with non-atopic 
controls within the same general practice. A total of 404 
International Classification of Primary Care codes were 
examined. Logistic regression analyses were performed to 
examine the associations between the presence of atopic 
disorders and (non-)atopic symptoms and diseases by 
calculating ORs.
results Having one of the atopic disorders significantly 
increased the risk of having other atopic-related 
symptoms, even if the child was not registered as 
having the related atopic disorder. Regarding non-atopic 
comorbidity, children with atopic eczema (n=15 530) were 
at significantly increased risk for (infectious) skin diseases 
(OR: 1.2–3.4). Airway symptoms or (infectious) diseases 
(OR: 2.1–10.3) were observed significantly more frequently 
in children with asthma (n=7887). Children with allergic 
rhinitis (n=6835) had a significantly distinctive risk of ear-
nose-throat-related symptoms and diseases (OR: 1.5–3.9). 
Neither age nor gender explained these increased risks.
conclusion General practitioners are not always fully 
aware of relevant atopic and non-atopic comorbidity. 
In children known to have at least one atopic disorder, 
specific attention is required to avoid possible insufficient 
treatment and unnecessary loss of quality of life.
IntrOductIOn
Atopic disorders represent an important 
health problem in general practice. Acute 
upper airway infections, middle ear infec-
tions, warts, asthma and atopic eczema 
represent the five most prevalent paediatric 
diseases diagnosed in general practice1; 
allergic rhinitis is on the 12th place on this 
list. However, limited data are available on 
the comorbidities of children with atopic 
disorders in primary care.2 In the present 
study we refer to atopy as a (genetic) predis-
position towards developing certain allergic 
hypersensitivity. Therefore the clinical 
manifestation of atopy is allergy. However, 
not all allergies are based on atopy. In this 
study the word ‘atopic’ refers to this genet-
ically mediated predisposition, which did 
result in the clinical diagnosis by a general 
practitioner (GP) of atopic eczema, asthma 
and allergic rhinitis.
Associations have been shown between 
atopic disorders and other diseases in 
children, but in different clinical settings 
(eg, birth cohorts, hospitals or paediatric 
clinics). Demonstrated interrelations exist 
with (among others) diabetes,3–5 atten-
tion-deficit/hyperactivity disorder,6–8 
autism9–11 and obesity.12–14 According to 
other studies, the presence of some comor-
bidities may even influence the course 
of atopic disorders. For example, acute 
upper airway infections, especially in early 
childhood, are related to atopic disorders 
later in life.15 16 Acute viral ‘non-respira-
tory syncytial virus’ bronchiolitis in infants 
aged <6 months is linked with an increased 
risk of developing asthma.17 The developing 
immune system of a child might be affected 
by frequent or severe infections of the 
middle ear, resulting in increased risk for 
asthma and atopic eczema.18 On the other 
hand, otitis media with effusion is associ-
ated with allergic rhinitis.19–21 The quality of 
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strengths and limitations of this study
 ► The present study used an extensive and 
representative general practice database.
 ► The large number of children gives the study 
substantial power and generalisability.
 ► A total of 404 International Classification of Primary 
Care codes were examined.
 ► A limitation regarding this type of explorative study 
is the unavoidable multiple testing.
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life of a child with atopic disorders can be significantly 
improved by providing sufficient treatment.
To our knowledge no study has investigated the 
complete range of potential comorbidities in children 
with atopic disorders in a general practice setting. A 
relevant question could be: Are children with atopic 
disorders at increased risk for non-atopic symptoms or 
diseases? Awareness by GPs of these risks may reduce 
the probability that relevant comorbidity is not diag-
nosed. To study possible associations between atopic 
disorders and 404 different symptoms and diseases, an 
extensive and representative nationwide general prac-
tice database is explored using a cross-sectional design. 
The design of this study allows new hypotheses to be 
generated, providing valuable input for future research.
MethOds
study population
All non-institutionalised residents in the Netherlands 
are registered in a general practice, even if they do 
not visit the GP on a regular basis. The Netherlands 
Institute for Health Services Research-Primary Care 
Database (NIVEL-PCD) is based on routinely recorded 
data in electronic health records (EHRs) of all listed 
patients in the participating practices. In 2014, about 
500 general practices participated, including data of 
about 1 700 000 patients (www. nivel. nl/ en/ dossier/ 
nivel- primary- care- database), which is over 10% of the 
total Dutch population. EHR data include a variety of 
information regarding type of consultation, morbidity 
and prescriptions. Data available for 2014 are represen-
tative for the Dutch population.22.
IcPc and episodes of care
Primary care physicians (gatekeepers for the Dutch 
healthcare system) recorded morbidity using the Inter-
national Classification of Primary Care (ICPC), a clas-
sification method for primary care that is accepted by 
the WHO.23 It has been translated in 22 languages and 
is now widely used for the routine collection of data 
on episodes of care, but also in encounter studies.24 
Routinely collected general practice computer data, 
aggregated into large databases, are used for epide-
miological research.25 Hippisley-Cox et al26 illustrate 
how routine clinical data, in selected high recording 
practices (this selection criterion was also applied in 
the present study), are now reaching reasonable levels 
of accuracy and completeness for a range of key vari-
ables. According to Britt et al27, morbidity data actively 
collected by GPs provide a reliable overview of morbidity 
managed in general practice.
Dutch GPs cluster relevant consultations, prescrip-
tions and referrals, in ICPC-classified ‘episodes of care’. 
An episode of care is a health problem or disease from 
its first presentation to the GP to the last presentation 
for the same problem. Atopic disorders are labelled 
with ICPC codes: S87 (atopic eczema), R96 (asthma) 
and R97 (allergic rhinitis). ICPC codes specific for 
food allergies are not available.
For the present study, only morbidity data from EHRs 
of general practices with sufficient data quality were 
used that fulfilled the following criteria: (1) at least 500 
listed patients (standard practice: 2350 patients), (2) 
complete morbidity registration (defined as ≥46 weeks/
year) and (3) sufficient ICPC coding of diagnostic 
information (defined as ≥70% of the recorded disease 
episodes labelled with an ICPC code; the average ICPC 
coding in a Dutch general practice is >95%). The 
following descriptive data were routinely collected: 
period in which the individual child was registered in 
the general practice, the unique code of the GP prac-
tice, the child’s gender, and year and quarter of birth.
children with atopic disorders
For each child (0–18 years), a minimum follow-up of 
3 years was required (eg, data had to be available for 
2012–2014) for the present study to reduce the risk 
of registration bias. For this reason, only data for chil-
dren aged ≥2 years are presented here. In the Nether-
lands, GPs see about 72% of their patient population 
at least once a year.28 We considered a 3-year follow-up 
period to be sufficient time for a GP to diagnose a child 
with (atopic) disorders. Furthermore, in order not to 
miss any relevant atopic diagnosis, when available, the 
EHRs from 2002 to 2014 were examined. Since GPs 
inevitably work with probability diagnoses, there is a 
risk of misclassification. To select cases with a higher 
probability of a clinically relevant disorder, ICPC codes 
and their related episodes of care can be corrected. In 
practice, an atopic episode of care was maintained if 
(between 2002 and 2014) the parent of the child had 
at least contacted the GP twice in that episode of care 
and had received at least two relevant prescriptions. 
If the child did not meet these criteria, the child was 
considered not to have that atopic disorder29 and was 
excluded from the study (this child could not be used 
as a control patient, to make sure that controls did not 
have any atopic disorder). If a child was diagnosed with 
an atopic disorder for the first time during 2014, the 
child was considered to have the atopic disorder that 
whole year. In the present study, the atopic diagnosis 
was based on the physician’s assessment and was consid-
ered to be a chronic problem.
Atopic triad
A recent meta-analysis supported the hypothesis that 
there might be a fourth distinct group of children 
with all three atopic disorders, in contrast to the 
traditional classification of children with asthma or 
allergic rhinitis or atopic eczema.30 To learn more about 
this potentially unique group of children, ‘atopic triad’ 
episodes were developed for research purposes. These 
episodes were only created when a child was diagnosed 
with all three atopic disorders, based on available data 
from EHRs in the period of 2002–2014.
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Only atopic eczema 15 530 8.7 (4.5) 48.2
Only asthma 7887 10.7 (4.5) 59.0
Only allergic rhinitis 6835 13.5 (3.5) 57.8
Atopic triad 559 11.6 (4.0) 61.4
NB: Children in the first three groups had only one of the three 
atopic disorders: that is, they had the disorder mentioned, but 
none of the other disorders, whereas children in the atopic triad 
group had all three disorders.
symptoms and diseases studied
After establishing which child had an atopic disorder 
(see above), a child was considered prevalent for a 
specific symptom or disease if the child had at least 
one active episode of care for that symptom or disorder 
between January and December of 2014. All ICPC 
codes that describe a symptom or a disease were exam-
ined, with the exception of trauma-related ICPC codes, 
ICPC codes not relevant for children (eg, presbycusis), 
pregnancy, childbearing, family planning, sexually 
transmitted diseases and social problems, leaving 404 
different ICPC codes. Furthermore, since different clas-
sifications are used for eczema, there is a risk of misclas-
sification. The ICPC system distinguishes the codes 
S86 (seborrheic dermatitis), S87 (atopic eczema), S88 
(contact dermatitis/eczema another) and S89 (diaper 
rash). Since clinical differentiation can be very diffi-
cult, especially between S87 and S88, S88 was excluded 
from our analyses, to get more reliable results for ‘true’ 
atopic eczema (S87).
design
An observational study design was used in which cases 
with one atopic disorder were matched with controls 
without any atopic disorder. For each child with atopic 
disorders, one matched control patient was selected 
(not diagnosed with an atopic disorder) within the 
same general practice, based on age and gender in 
2014. Controls were only matched if a 100% match 
on age, gender and general practice with a child with 
atopic disorders was determined. ORs were calculated 
for children who solely had atopic eczema, asthma or 
allergic rhinitis and therefore no other atopic comor-
bidity. Online supplementary appendix 1 presents a list 
of all the ICPC codes that were examined. A 1:1 ratio 
was chosen to be able to include as many pairs of cases 
and controls as possible, allowing the results to carry 
more weight and making the conclusions more gener-
alisable to future populations. In the present study, a 
1:2 ratio would have resulted in dropping over 40% of 
the cases.
statistical analyses
Logistic regression analysis was performed to study asso-
ciations between the presence of atopic disorders and 
(non-)atopic comorbid symptoms and diseases in chil-
dren. Similarly, associations between atopic triad and 
the above-mentioned comorbid symptoms and diseases 
were examined. Due to multiple testing, only associa-
tions with p≤0.001 were considered statistically signif-
icant. All associations were tested for the modifying 
effects of age and gender. In case of a significant effect 
(p≤0.01), associations were also presented for subgroups 
for age (2–6 vs 7–12 vs 13–18 years) and gender (boy vs 
girl). Finally, due to the hierarchical structure of the 
data (patients registered in general practices), a multi-
level logistic regression analysis was performed to test 
whether clustering effects influenced our findings. All 
analyses were conducted on Stata V.13 and Excel 2010. 
Prevalence rates are presented in percentages.
results
General characteristics 
There were 409 312 children identified in the NIVEL-PCD 
in 2014, initially including 70 494 children with at least 
one atopic disorder. However, for a child with atopic 
disorder to be included in this study, one matched 
control patient had to be available (ie, a child without 
an atopic disorder). There were 21 285 children with 
atopic eczema identified, of whom 15 530 children had 
atopic eczema without another atopic disorder. For 
children with asthma, 13 196 children were identified, 
of whom 7887 had asthma only and no other atopic 
disorders. In children with allergic rhinitis, 11 483 were 
identified, of whom 6835 had allergic rhinitis without 
another atopic disorder. Finally, 559 children had all 
three atopic disorders. All the children in these groups 
were selected from 316 different general practices 
participating in NIVEL-PCD. Clustering effects did not 
influence our findings (table 1).
Atopic eczema 
A substantial part of the significantly related comor-
bidity for children with atopic eczema concerns skin 
diseases such as (among others) warts (OR: 1.2), 
localised rash (OR: 1.5), pruritus (OR: 1.7), impetigo 
(OR: 1.7), dermatophytosis (OR: 1.8), urticaria (OR: 
1.8), molluscum contagiosum (OR: 1.9) and psoriasis 
(OR: 3.4). Otitis externa (OR: 1.6) and blepharitis 
(OR: 1.5) were also significantly associated with atopic 
eczema. The symptom diagnosis of wheezing (OR: 2.0), 
which could be attributed to asthma, is noteworthy since 
these children were not diagnosed or coded in the EHRs 
with asthma. The same applies to symptoms associated 
with allergic rhinoconjunctivitis, such as sneezing/
nasal congestion (OR: 2.0) and allergic conjunctivitis 
(OR: 2.0). Older children with atopic eczema were 
at increased risk to develop a localised rash (OR: 1.3 
to 2.3) and impetigo (OR: 1.5 to 2.7). Compared with 
boys, girls had an increased risk to develop a localised 
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Table 2 Significantly (p≤0.001) associated comorbidity in children diagnosed with only atopic eczema (Ec) and at least 3-year 
follow-up versus controls (non-atopic children) (n=31 060)
ICPC Description of ICPC codes OR 95% CI Prevalence OR sex OR age
Ec No Ec Boy Girl 2–6 7–12 13–18
Skin-related diseases and symptoms
S03 Warts 1.15 1.06 to 1.26 7.85 6.88
S06 Rash localised* † 1.51 1.25 to 1.82 1.76 1.18 1.11 2.02 1.29 1.54 2.30
S99 Skin disease, other 1.57 1.24 to 2.00 1.12 0.71
S02 Pruritus 1.71 1.31 to 2.23 0.97 0.57
S84 Impetigo† 1.71 1.54 to 1.90 6.23 3.75 1.54 1.78 2.72
S04 Lump/swelling, localised 1.76 1.30 to 2.39 0.73 0.42
S74 Dermatophytosis 1.76 1.54 to 2.00 4.20 2.44
S98 Urticaria 1.77 1.50 to 2.09 2.49 1.42
S21 Skin texture symptom/complaint 1.89 1.49 to 2.40 1.26 0.67
S95 Molluscum contagiosum 1.92 1.69 to 2.19 4.44 2.38
S86 Seborrhoeic dermatitis 2.31 1.87 to 2.84 1.89 0.83
S91 Psoriasis 3.36 2.23 to 5.06 0.64 0.19
Airway-related diseases and symptoms
R05 Cough 1.29 1.17 to 1.43 5.94 4.67
R74 Upper respiratory infection, acute 1.33 1.23 to 1.43 10.42 8.13
R78 Acute bronchitis/bronchiolitis 1.49 1.22 to 1.80 1.66 1.13
R04 Breathing problem, other* 1.55 0.97 to 2.48 0.29 0.19 0.91 3.58
R03 Wheezing 1.95 1.30 to 2.92 0.45 0.23
Ear-nose-throat-related diseases and symptoms
H71 Acute otitis media/myringitis 1.20 1.09 to 1.31 7.46 6.35
H72 Serous otitis media 1.40 1.21 to 1.62 2.92 2.11
H01 Ear pain/earache 1.43 1.24 to 1.65 3.01 2.13
H04 Ear discharge 1.47 1.17 to 1.86 1.13 0.77
R21 Throat symptom/complaint 1.50 1.27 to 1.78 2.13 1.43
H70 Otitis externa 1.56 1.27 to 1.90 1.58 1.02
R07 Sneezing/nasal congestion 1.95 1.32 to 2.89 0.48 0.24
Gastrointestinal-related diseases and symptoms
D01 Abdominal pain/cramps, general 1.27 1.12 to 1.45 3.61 2.85
D12 Constipation 1.32 1.19 to 1.47 5.29 4.07
D87 Stomach function disorder* 1.48 0.87 to 2.51 0.22 0.15 0.69 3.29
D99 Disease digestive system, other 2.28 1.51 to 3.44 0.48 0.21
Musculoskeletal
L17 Foot/toe symptom/complaint 1.30 1.15 to 1.48 3.50 2.71
L98 Acquired deformity of limb 1.39 1.20 to 1.60 2.90 2.11
Miscellaneous
A04 Weakness/tiredness, general 1.25 1.09 to 1.44 3.07 2.47
S12 Insect bite/sting 1.41 1.19 to 1.66 2.24 1.60
F72 Blepharitis/stye/chalazion† 1.53 1.22 to 1.93 1.20 0.79 0.96 2.79 1.76
F70 Infectious conjunctivitis 1.53 1.29 to 1.81 2.18 1.44
Y81 Phimosis/redundant prepuce 1.83 1.47 to 2.72 1.49 0.83
F71 Allergic conjunctivitis 1.99 1.59 to 2.49 1.45 0.73
A12 Allergy 3.11 2.62 to 3.69 3.42 1.13
Italics mean overall model not significant.
*Significant (p≤0.01) influence of gender.
†Significant (p≤0.01) influence of age.
ICPC, International Classification of Primary Care.
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Table 3 Significantly (p≤0.001) associated comorbidity in children diagnosed with only asthma (As) and at least 3-year follow-
up versus controls (non-atopic children) (n=15 774)
ICPC Description of ICPC codes OR 95% CI Prevalence OR sex OR age
As No As Boy Girl 2–6 7–12 13–18
Skin-related diseases and symptoms
S98 Urticaria 2.10 1.61 to 2.73 2.21 1.07
Airway-related diseases and symptoms
R05 Cough 2.14 1.86 to 2.46 7.99 3.93
R77 Laryngitis/tracheitis, acute 2.34 1.54 to 3.56 0.94 0.41
R74 Upper respiratory infection 2.35 2.09 to 2.64 12.34 5.78
R81 Pneumonia 4.04 3.03 to 5.37 2.97 0.76
R78 Acute bronchitis/bronchiolitis† 4.80 3.78 to 6.11 4.79 1.05 3.74 5.63 8.09
R91 Chronic bronchitis 5.66 3.14 to 10.23 0.93 0.16
R02 Shortness of breath/dyspnoea 7.74 5.05 to 11.87 2.31 0.30
R03 Wheezing 10.30 4.73 to 22.42 0.90 0.09
Ear-nose-throat-related diseases and symptoms
H76 Foreign body in ear* 0.86 0.40 to 1.85 0.15 0.18 2.51 0.20
H01 Ear pain/earache 1.45 1.16 to 1.81 2.46 1.71
H71 Acute otitis media/myringitis 1.52 1.32 to 1.76 6.44 4.4
H70 Otitis externa 1.60 1.22 to 2.08 1.79 1.13
R75 Sinusitis acute/chronic 1.90 1.32 to 2.75 1.05 0.56
Gastrointestinal-related diseases and symptoms
D89 Inguinal hernia* 0.76 0.37 to 1.57 0.16 0.22 0.27 4.52
D01 Abdominal pain/cramps, general 1.40 1.16 to 1.69 3.32 2.40
D06 Abdominal pain, localised, other 1.43 1.15 to 1.77 2.59 1.83
D12 Constipation 1.44 1.22 to 1.70 4.43 3.12
D73 Gastroenteritis, infection 1.60 1.25 to 2.05 2.10 1.33
D10 Vomiting 2.02 1.37 to 2.97 0.99 0.49
D99 Disease digestive system, other 2.70 1.52 to 4.79 0.55 0.20
Musculoskeletal
L15 Knee symptom/complaint† 1.11 0.90 to 1.37 2.42 2.18 1.34 1.49 0.97
L12 Hand symptom/complaint* 1.37 1.09 to 1.71 2.27 1.67 1.00 2.13
L98 Acquired deformity of limb 1.40 1.16 to 1.68 3.54 2.56
L99 Musculoskeletal disease, other 1.52 1.22 to 1.89 2.66 1.78
L11 Wrist symptom/complaint 1.98 1.48 to 2.65 1.71 0.87
Miscellaneous
P21 Attention-deficit/hyperactivity disorder 1.34 1.13 to 1.58 4.18 3.17
A04 Weakness/tiredness, general 1.39 1.17 to 1.65 4.04 2.97
N01 Headache 1.51 1.21 to 1.89 2.49 1.66
F70 Infectious conjunctivitis 1.72 1.31 to 2.27 1.78 1.04
T10 Growth delay 1.82 1.35 to 2.44 1.60 0.89
T83 Overweight 2.09 1.41 to 3.10 0.98 0.47
T82 Obesity 2.47 1.50 to 4.05 0.68 0.28
F71 Allergic conjunctivitis 2.55 1.85 to 3.49 1.72 0.68
A12 Allergy 3.40 2.74 to 4.23 4.55 1.38
Italics mean overall model not significant.
*Significant (p≤0.01) influence of gender.
†Significant (p≤0.01) influence of age.
ICPC, International Classification of Primary Care.
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Table 4 Significantly (p≤0.001) associated comorbidity in children diagnosed with only allergic rhinitis (AR) and at least 3-year 
follow-up versus controls (non-atopic children) (n=13 670)
ICPC Description of ICPC codes OR 95% CI Prevalence OR sex OR age
AR No AR Boy Girl 2–6 7–12 13–18
Skin-related diseases and symptoms
A76 Viral exanthem, other† 0.86 0.47 to 1.60 0.28 0.32 0.32 0.64 4.51
S03 Warts 1.26 1.10 to 1.43 7.65 6.20
S74 Dermatophytosis 1.39 1.15 to 1.68 3.85 2.79
S82 Naevus/mole 1.39 1.15 to 1.67 3.99 2.91
S84 Impetigo 1.71 1.35 to 2.15 2.87 1.71
S98 Urticaria 1.71 1.31 to 2.23 2.15 1.27
S86 Seborrheic dermatitis 1.86 1.38 to 2.53 1.76 0.95
S02 Pruritus 2.21 1.44 to 3.38 0.99 0.45
Airway-related diseases and symptoms
R05 Cough 1.89 1.58 to 2.25 5.24 2.85
R74 Upper respiratory infection, acute 1.92 1.66 to 2.23 8.00 4.35
R78 Acute bronchitis/bronchiolitis 2.32 1.60 to 3.37 1.35 0.59
R02 Shortness of breath/dyspnoea 2.67 1.74 to 4.11 1.13 0.42
R80 Influenza 3.89 1.79 to 8.47 0.45 0.12
R03 Wheezing 4.30 1.89 to 9.80 0.44 0.10
Ear-nose-throat-related diseases and symptoms
R21 Throat symptom/complaint 1.48 1.20 to 1.84 3.13 2.14
H01 Ear pain/earache 1.87 1.36 to 2.56 1.62 0.88
R90 Hypertrophy tonsils/adenoids† 1.92 1.34 to 2.74 1.30 0.69 3.22 2.80 1.04
R75 Sinusitis acute/chronic 1.95 1.45 to 2.63 1.89 0.98
R08 Nose symptom/complaint, other 2.62 1.72 to 4.00 1.14 0.44
R07 Sneezing/nasal congestion 3.93 2.57 to 6.01 1.54 0.40
Gastrointestinal-related diseases and symptoms
D12 Constipation 1.50 1.23 to 1.82 3.79 2.57
D06 Abdominal pain, localised, other 1.76 1.39 to 2.22 2.90 1.67
D73 Gastroenteritis, presumed infection* 1.96 1.42 to 2.71 1.59 0.82 1.29 3.39
Musculoskeletal
L98 Acquired deformity of limb 1.36 1.15 to 1.62 4.54 3.37
L17 Foot/toe symptom/complaint 1.42 1.19 to 1.70 4.40 3.15
L13 Hip symptom/complaint 2.80 1.66 to 4.74 0.78 0.28
Miscellaneous
N19 Speech disorder* 1.18 0.85 to 1.65 1.17 0.99 0.89 2.43
N01 Headache 1.45 1.18 to 1.78 3.29 2.30
P24 Specific learning problem 1.45 1.18 to 1.78 3.37 2.37
A04 Weakness/tiredness, general 1.58 1.35 to 1.85 6.10 3.96
F70 Infectious conjunctivitis 1.73 1.28 to 2.32 1.76 1.02
S12 Insect bite/sting 1.92 1.40 to 2.63 1.67 0.88
F72 Blepharitis/stye/chalazion* 1.95 1.36 to 2.79 1.27 0.66 1.21 3.29
A12 Allergy 4.02 3.15 to 5.13 4.70 1.21
F71 Allergic conjunctivitis 5.44 4.08 to 7.25 4.29 0.82
Italics mean overall model not significant.
*Significant (p≤0.01) influence of gender.
 †Significant (p≤0.01) influence of age.
ICPC, International Classification of Primary Care.
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Table 5 Significantly (p≤0.001) associated comorbidity in children diagnosed with atopic triad and at least 3-year follow-up 
versus controls (non-atopic children) (n=1118)
ICPC Description of ICPC codes OR 95% CI Prevalence
Atopic triad No atopic triad
R05 Cough 2.42 1.43 to 4.10 8.59 3.76
L17 Foot/toe symptom/complaint 3.25 1.63 to 6.50 6.08 1.97
R74 Upper respiratory infection, acute 3.75 2.33 to 6.04 14.13 4.29
F71 Allergic conjunctivitis  6.79 2.35 to 19.60 4.65 0.72
A12 Allergy 17.83 7.15 to 44.43 13.77 0.89
ICPC, International Classification of Primary Care.
rash (OR: 2.0 vs 1.1), breathing problems (OR: 3.6 vs 
0.9) and stomach function disorder (OR: 3.3 vs 0.7) 
(table 2).
Asthma 
Noteworthy are asthma-related symptoms that were 
diagnosed separately, such as shortness of breath/
dyspnoea (OR: 7.7) and wheezing (OR: 10.3). Further-
more, children with asthma were presented to their 
GPs more frequently for airway-related infections such 
as acute laryngitis/tracheitis (OR: 2.3), acute upper 
respiratory infection (OR: 2.4), pneumonia (OR: 4.0) 
and acute bronchitis (OR: 4.8). In children with asthma, 
there seems to be a higher risk for the development of 
gastrointestinal symptoms, for example, general abdom-
inal pain/cramps (OR: 1.4), localised abdominal pain 
(OR: 1.4), constipation (OR: 1.4) and vomiting (OR: 
2.0). Acute bronchitis (OR: 3.7 to 8.1) was diagnosed 
more often in older children. Inguinal hernias were 
seen more frequently in girls than in boys (OR: 4.5 vs 
0.3) (table 3).
Allergic rhinitis 
Children with allergic rhinitis were presented to their 
GPs more frequently for ear-nose-throat-related symp-
toms and diseases. Among others, the following were 
diagnosed more often: throat symptom/complaint (OR: 
1.5), ear pain/earache (OR: 1.9), hypertrophy tonsils/
adenoids (OR: 1.9), acute/chronic sinusitis (OR: 2.0), 
nose symptom (OR: 2.6) and sneezing/nasal conges-
tion (OR: 3.9). Furthermore, symptoms associated with 
atopic eczema (pruritus; OR: 2.2) and asthma (shortness 
of breath/dyspnoea (OR: 2.7) and wheezing (OR: 4.3)) 
were seen more frequently. Also, when a child was diag-
nosed with allergic rhinitis, there was a substantial risk for 
the development of gastrointestinal symptoms (constipa-
tion (OR: 1.5) and localised abdominal pain (OR: 1.8)). 
Hypertrophy of the tonsils was diagnosed less frequently 
when children got older (OR: 3.2 to 1.0). On the other 
hand, children were more frequently diagnosed with a 
viral exanthem when they became older (OR: 0.3 to 4.5). 
A presumed gastrointestinal infection (OR: 3.4 vs 1.3), 
speech disorder (OR: 2.4 vs 0.9) and blepharitis/style/
chalazion (OR: 3.3 vs 1.2) were diagnosed more frequently 
in girls with allergic rhinitis (table 4).
Atopic triad
Having all three atopic disorders is relatively rare, with 
only a few symptoms and diseases being significantly 
related. The risk for developing an ‘allergy’ that the GP 
considers relevant to register in the EHR can be consid-
ered high (OR: 17.8). Allergic conjunctivitis (OR: 6.8) 




The present study used an extensive and representative 
general practice database.22 The large number of chil-
dren gives the study substantial power and generalis-
ability. This could also allow evaluation of possible links 
between atopic disorders and rare childhood diseases. 
This study showed that children with atopic disorders 
have an increased risk for the development of both 
atopic and non-atopic diseases and symptoms. Children 
diagnosed with one atopic disorder were frequently 
diagnosed by their GP with symptoms associated with 
one of the (other) atopic disorder(s). This suggests that 
GPs are not always fully aware of relevant atopic comor-
bidity, or at least do not label it correctly. Two examples 
support this hypothesis. First of all, a child diagnosed with 
atopic eczema is also diagnosed with pruritus, suggesting 
possible misclassification. Second, a child with atopic 
eczema who is presented with ‘wheeze’ or ‘dyspnea’ is at 
a higher risk for the development of asthma compared 
with a child without atopic eczema. A GP should be aware 
of this increased risk, since it could result in insufficient 
treatment of a child. However, a GP could also use symp-
tom-related ICPC codes deliberately when the purpose 
is to record a provisional diagnosis (eg, wheeze as the 
provisional diagnosis of asthma). Regarding non-atopic 
comorbidity, strong associations were found between the 
atopic disorder and diseases and symptoms related to the 
same organ system. For example, children with atopic 
eczema are at increased risk for the development of other 
skin diseases, children with asthma are at risk of other 
airway diseases, and children with allergic rhinitis are at 
risk of ear-nose-throat-related symptoms and diseases. 
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Gastrointestinal and musculoskeletal diseases and symp-
toms were also seen more frequently in children with 
atopic disorders. When exploring possible interactions of 
age and gender in children with one atopic disorders, no 
clear patterns arose.
Interpretation of findings in relation to previously published 
work
Children with atopic eczema had an increased risk of 
developing infectious skin diseases such as warts, impe-
tigo, dermatophytosis and molluscum contagiosum. The 
common aetiology could be the barrier dysfunction of the 
skin in children with atopic eczema. This barrier dysfunc-
tion is also seen in psoriasis, a disease that, according to 
the present study, is associated with atopic eczema (OR: 
3.4). They share some common pathological backgrounds 
such as barrier dysfunction and enhanced interleukin-22 
expression.31 Although the clinical pictures of these two 
diseases can be very different, the observed association 
could also suggest misclassification among these two 
chronic skin diseases that are often confused for one 
another. Otitis externa and blepharitis both had signifi-
cant ORs. These disorders could in fact be an expression 
of atopic eczema.
Children with asthma seem to have been presented 
to their GPs more frequently for airway-related infec-
tions such as acute laryngitis/tracheitis, acute upper 
respiratory infection, pneumonia and bronchitis. This 
is in agreement with another primary healthcare study.2 
An explanation for this could be that airway infections 
increase asthma symptoms or vice versa, and that asthma 
resulted in increased susceptibility for infection, which 
increased their motivation to visit the GPs. Furthermore, 
the awareness of parents is likely to be increased when a 
child suffers from asthma, since such an infection could 
predispose for an asthma exacerbation.
Children with allergic rhinitis were presented to their 
GPs more frequently for ear-nose-throat-related symp-
toms and diseases. However, even more striking are the 
asthma-related symptoms. Both shortness of breath (OR: 
2.7) and wheeze (OR: 4.3) were frequently seen in chil-
dren with allergic rhinitis. There is strong evidence that 
allergic rhinitis has an adverse impact on asthma severity.32 
Because allergic rhinitis can provoke asthma symptoms, 
allergic rhinitis symptoms should be taken more seriously 
by GPs to reduce insufficient treatment.
Gastrointestinal-related symptoms are also frequently 
diagnosed by GPs in children with atopic disorders. This 
is in accordance with a study in adults in a primary care 
setting.33 These symptoms could be related to IgE-medi-
ated food allergies or in rare cases even to eosinophilic 
oesophagitis, which is associated with atopic disorders34; 
however, in children, abdominal pains can also be a 
general expression of not feeling well. Unfortunately, the 
ICPC classification system does not cover the above-men-
tioned gastrointestinal diseases with unique code, and 
therefore gastrointestinal-related symptoms might have 
been used by the GP to label these diseases.
Some associations described in the literature were not 
confirmed in the present study, for example, serous otitis 
media in patients with allergic rhinitis,19 21 and inflamma-
tory bowel disease,35 36 leukaemia37 38 and diabetes39 40 in 
patients with atopic disorders. The prevalences of some 
of these disorders are low and a cross-sectional design (as 
used in the present study) might not have enough power 
to prove these relationships.
strengths and limitations of this study
Using general practice databases (by means of a cross-sec-
tional design) also has its limitations. First of all, a limita-
tion for the present study is the GP’s choice for ICPC 
coding of an episode of care. For example, a child with 
a wheeze could either be labelled as ‘asthma’ (R96) or 
labelled as ‘wheeze’ (R03). This could result in both over-
estimation or underestimation of asthma. To decrease this 
risk of overestimation regarding atopic disorders, some 
episodes were corrected in order to increase the clinical 
relevance of the atopic disorder of interest. However, the 
risk of underestimation was not tackled, since too many 
assumptions need to be made. The second limitation 
regarding this type of explorative study is the unavoidable 
multiple testing. Although conservative p values were 
used, type 1 errors cannot be avoided. In this study, some 
suggested associations might in fact reflect these type 1 
errors. Third, because data on socioeconomic status, 
tobacco smoke exposure and other lifestyle-related risk 
factors are not recorded in NIVEL-PCD, we cannot rule 
out the effect of these risk factors on the observed rela-
tions. However, since the children with atopic disorders 
were matched with controls within the same general prac-
tice, all children are most likely living in the same neigh-
bourhoods, and therefore the effect of most of the earlier 
mentioned risk factors is expected to be small. Fourth, 
children with atopic disorders might be presented to 
the GP more frequently than non-atopic children. And 
although this may be more representative of parental 
fears, rather than an indication of morbidity, it can result 
in more detected morbidity in children with atopic disor-
ders and could partly explain some of the associations 
found. In future research, the number of consultations 
might need to be taken into account in the analyses. 
Fifth, in the present study the diagnoses are based on a 
physician’s assessment and not on confirmed sensitisation 
pattern for allergens. According to the Dutch medical 
guideline for eczema,41 GPs are not advised to determine 
these sensitisation patterns, since these do not have any 
clinical consequences. Although atopy is clearly associ-
ated with atopic eczema, the role of IgE sensitisation in 
atopic eczema still needs further study.42 Also in chil-
dren with allergic rhinitis, sensitisation patterns do not 
have added value if the medical history clearly suggests, 
for example, a pollen allergy.43 Only when the cause of 
the rhinitis is uncertain the determination of sensitisation 
patterns adds value. The medical guidelines for asthma 
in children advise to determine sensitisation patterns,44 
since it can help diagnose allergic asthma45 and because it 
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could have clinical consequences. Finally, it is important 
to acknowledge the uncertainty of GPs to make a diag-
nosis of asthma or allergic rhinitis in young children (eg, 
under the age of 6).
Implications for future research and practice
First of all, could comorbidity data be used to create 
proxies that could support GPs in identifying children 
with atopic disorders that are not labelled as such? For 
example, could comorbidity data be incorporated in ‘clin-
ical decision support systems’ to improve early diagnosis 
of both atopic and non-atopic disorders. Second, how is 
the quality of life of these children with atopic disorders 
affected by the associated comorbidity? GPs should be 
aware of the described associations when treating a child 
with atopic disorder, since the quality of life of a child 
with atopic disorder could be improved by paying more 
attention to diagnosis and treatment of these related 
disorders. Furthermore, one must be aware that atopic 
disorders and associated symptoms and diseases may well 
persist into adulthood.
cOnclusIOns
The present study shows that children with atopic disor-
ders have an increased risk of clinically relevant comor-
bidity, both atopic and non-atopic. GPs may not always be 
fully aware of relevant atopic and non-atopic comorbidity. 
In children known to have at least one atopic disorder, 
specific attention is required to avoid possible insufficient 
treatment and unnecessary loss of quality of life.
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